Veru soars over 25% as FDA discusses its COVID drug



The shares of pharma company Veru Inc. jumped more than 25% on Monday on the news the United States Food and Drugs Administration began discussions on approving its COVID-19 treatment.

The FDA’s …

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento